Investors need to pay close attention to About Alkermes (ALKS) stock based on the movements in the options market lately.

Alkermes is positioned for outperformance due to its conservative cash-heavy balance sheet and high-margin business model.

The price-to-earnings ratio for Alkermes plc (NASDAQ:ALKS) is 9.65. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E ...

Alkermes plc (Nasdaq: ALKS) today announced the presentation of research related to its psychiatry franchise ...

Alkermes plc last week announced it had completed the sale of its development and manufacturing facility in Athlone, to Novo ...

Stifel Nicolaus analyst Paul Matteis maintained a Hold rating on Alkermes (ALKS – Research Report) yesterday and set a price target of $28.00. The company’s shares closed yesterday at $23.86.

Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility ...

Alkermes (NASDAQ:ALKS) just reported results for the first quarter of 2024. Alkermes reported earnings per share of 44 cents. This was below the analyst estimate for EPS of 58 cents. The company ...

DUBLIN (AP) — DUBLIN (AP) — Alkermes PLC (ALKS) on Wednesday reported first-quarter net income of $36.8 million, after reporting a loss in the same period a year earlier. The Dublin-based ...

The market expects Alkermes (ALKS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook ...